Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, replacing the previous revision. This reflects a minor update to the page's revision history and metadata.
    Difference
    0.1%
    Check dated 2026-05-16T09:22:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor software/UI update rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-25T06:14:30.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:21.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Publications section updated: replaced the 2025 online-ahead-of-print citation with the 2026 J Thorac Oncol article by Chen MF et al.
    Difference
    0.1%
    Check dated 2026-04-03T18:56:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T05:21:52.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The bottom revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:38:39.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.